Key facts
- Ostoform’s last known valuation is $27.4M (Oct 2021).
- It has raised $7.8M.
- Notable investors include Enterprise Ireland, European Innovation Council, SOSV, BGF (Financial Services), AIB Start-Up Academy — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Ostoform
- ·The full record, as it builds
Funding rounds
No funding rounds for Ostoform are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ostoform
Developer of a medical device designed to manage skin complications suffered by ostomy patients. The company's device uses patented technology and is secured around the skin to effectively guide the corrosive stoma output into the ostomy bag, thereby preventing it from contacting the skin, enabling patients to prevent leakage and improve skin health.
- Sector
- Healthcare
- HQ
- Mullingar, Ireland
- Founded
- 2016
- Employees
- 15
- Website
- ostoform.com/
- Ownership
- Privately Held (backing)
Ostoform doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ostoform shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ostoform in its N-PORT filings yet. We sweep new filings monthly.